Condition

Colon and Rectal Cancer clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Colon and Rectal Cancer clinical trials that are recruiting, at sites in 3 countries (most in Portugal (1), United States (1), China (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Colon and Rectal Cancer clinical trials

StudyPhaseWhereStatusRegistered
INV-8989 in KRAS G12D-mutant advanced solid tumors Phase 1/2 Guangzhou, Guangdong Recruiting May 28, 2026
Combining gemcitabine, cisplatin, nab-paclitaxel and cemiplimab to shrink locally advanced biliary tract cancer Phase 2 New York, New York Recruiting Feb 25, 2026
Improving colorectal cancer screening adherence in Barcelos and Esposende — Porto Recruiting May 14, 2025

All recruiting trials (3)

Related topics

Advance Solid TumorsEndometrial CancerNon-small Cell Lung Cancer (NSCLC)Ovarian CancerCemiplimab

Quick answers

How many Colon and Rectal Cancer clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Portugal (1 trial), United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.